Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Women need more of the HIV drug Truvada than men to prevent infection

Women need daily doses of the antiviral medication Truvada to prevent HIV infection while men only need two doses per week due to the way the drug accumulates in different body tissues, according to a new study from pharmacy researchers the University of North Carolina at Chapel Hill.

Published
04 March 2016
From
Eurekalert Medicine & Health
Maraviroc may work as PrEP in combination with another drug – but probably not by itself

Two studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) outlined the first findings from the NEXT-PrEP study, otherwise known as HPTN 069.

Published
03 March 2016
By
Gus Cairns
San Francisco HIV providers: What did you learn at CROI 2016?

The HIV community has a lot of information to digest after an annual CROI (Conference on Retroviruses and Opportunistic Infections) conference. BETA wanted to distill some of these important findings by asking some prominent San Francisco Bay Area providers to give us their take on the conference. We asked, “What did you find interesting? What did you find exciting? And, what did you learn?”

Published
03 March 2016
From
BETA blog
ABIVAX’s Novel Approach to Treat HIV Demonstrates Safety and Preliminary Anti-viral Activity in Phase IIa

ABX464 is an orally available therapeutic that blocks HIV replication through an entirely novel mechanism, i.e. the modulation of the biogenesis of viral RNA, and acts by targeting the Rev protein.

Published
02 March 2016
From
Abivax press release
Dumbing Down Treatment Decisions, Part Two

Bob Leahy say there are wrong decisions made - both regarding treatment and prevention - all the time. But how do we help our most vulnerable who face barriers to good decision-making avoid them?

Published
02 March 2016
From
Positive Lite
Gilead Sciences Announces FDA Approval of Odefsey as HIV-1 Treatment in Certain Patients

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Odefsey® (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg or R/F/TAF) for the treatment of HIV-1 infection in certain patients.

Published
02 March 2016
From
Gilead press release
Rate of entry into HIV care improved by personalised counselling

Entry into HIV care can be increased by around 40% if people receive a point-of-care CD4 test and counselling sessions to overcome personal barriers to seeking HIV

Published
01 March 2016
By
Keith Alcorn
Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

Engaging lay counsellors to provide a combination package of evidence-based interventions in Nyanza, Kenya and addressing partner disclosure, as well as pre-treatment education about the benefits of antiretroviral

Published
01 March 2016
By
Carole Leach-Lemens
Vaginal ring for HIV prevention: a few details would have elevated good coverage to great

Analysis of BuzzFeed's coverage of vaginal ring studies.

Published
01 March 2016
From
Health News Review
Really Rapid Review — CROI 2016, Boston

Here is a carefully curated (I’m joking) list of highlights, a Really Rapid Review™ roughly divided into epidemiology/prevention, treatment, complications, cure — and coffee.

Published
01 March 2016
From
NEJM Journal Watch

Filter by country